pharmaphorum March 30, 2022
LetsGetChecked, a specialist in at-home diagnostic testing, has added genomics to its technology base with the acquisition of Veritas for an undisclosed amount.
The company said that the deal would allow it to add whole genome sequencing (WGS) to its range, giving it what it claims will be the most comprehensive health testing offering in the market, with everything from prenatal screening to predictive medicine.
Absorbing Veritas will take Ireland-headquartered LetsGetChecked into a market where Veritas vies with other WGS players like 23andMe, Nebula Genomics and Variantyx.
Founded in 2014, Boston-based Veritas was the first company to break the $1,000 barrier for whole genome sequencing, and since then has dropped the price to a few hundred dollars, whilst refining its...
Today's Sponsors
Today's Sponsor